Can you provide a hypertension management template?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hypertension Management Template

Use a structured, evidence-based approach incorporating accurate blood pressure measurement, risk stratification, lifestyle modifications, and algorithmic pharmacotherapy to achieve target blood pressure goals and reduce cardiovascular morbidity and mortality. 1, 2

1. Blood Pressure Measurement & Diagnosis

Measurement Technique

  • Use validated automated upper arm cuff device with appropriate cuff size 1
  • Measure both arms simultaneously at first visit; use arm with higher reading for subsequent measurements 1
  • Automated office BP ≥135/85 mmHg is equivalent to ambulatory BP ≥135/85 mmHg (awake) or ≥130/80 mmHg (24-hour) 3

Diagnostic Criteria

Hypertension is diagnosed when:

  • Office BP ≥140/90 mmHg on repeated measurements over 2-3 visits 1
  • Confirm with home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg 1

Accelerated diagnosis for high-risk patients:

  • Patients with diabetes, CKD (GFR <60), or macrovascular target organ damage can be diagnosed at visit 2 if BP ≥140/90 mmHg 3
  • Patients without these conditions but BP ≥180/110 mmHg can be diagnosed at visit 2 3

2. Risk Stratification & Assessment

Essential Baseline Evaluation

  • Cardiovascular risk assessment using validated tools (ASCVD, QRISK2, or SCORE) 1
  • Screen for target organ damage:
    • Renal function: serum creatinine, GFR, urinalysis for proteinuria/microalbuminuria
    • Cardiac: ECG; consider echocardiography if indicated
    • Metabolic: fasting glucose, HbA1c, lipid panel
    • Electrolytes: potassium, sodium 3

Screen for Secondary Hypertension When:

  • Age <30 years with hypertension
  • Sudden onset or worsening hypertension
  • Resistant hypertension (uncontrolled on ≥3 drugs)
  • Hypokalemia, abdominal bruit, or other suggestive features 3

3. Blood Pressure Targets

Standard target: <140/90 mmHg for all patients 3, 1

Individualized targets:

  • Diabetes or CKD: <130/80 mmHg 3, 4
  • Elderly/frail patients: Individualize based on frailty; may accept <150/90 mmHg 1
  • High cardiovascular risk: Consider <130/80 mmHg 2

4. Lifestyle Modifications (ALL Patients)

Dietary Sodium Restriction

  • Age ≤50 years: 1500 mg/day (65 mmol/day)
  • Age 51-70 years: 1300 mg/day (57 mmol/day)
  • Age >70 years: 1200 mg/day (52 mmol/day) 3

DASH Diet

  • Emphasize: Fruits (4-5 servings/day), vegetables (4-5 servings/day), low-fat dairy (2-3 servings/day), whole grains (7-8 servings/day), nuts/seeds/legumes (4-5 servings/week)
  • Limit: Saturated fat, cholesterol, sweets (≤5 servings/week) 3

Physical Activity

  • 30-60 minutes of moderate aerobic exercise, 4-7 days per week 3

Weight Management

  • Target BMI: 18.5-24.9 kg/m²
  • Waist circumference: ≤102 cm (men), ≤88 cm (women) 3

Alcohol Limitation

  • Men: ≤14 standard drinks/week
  • Women: ≤9 standard drinks/week 3

Stress Management

  • Consider in selected individuals 3

5. Pharmacotherapy Algorithm

When to Start Drug Therapy

Immediate drug therapy:

  • Grade 2 hypertension (≥160/100 mmHg) 1
  • Grade 1 hypertension (140-159/90-99 mmHg) with:
    • Diabetes, CKD, CVD, target organ damage, or age 50-80 years 1

Delayed drug therapy (after 3-6 months lifestyle modification):

  • Grade 1 hypertension (140-159/90-99 mmHg) in low-moderate risk patients without above conditions 1

Initial Drug Selection by Patient Profile

Non-Black Patients Without Compelling Indications

Step 1: Low-dose ACE inhibitor or ARB 3, 1

  • Alternative: Thiazide diuretic, long-acting CCB, or β-blocker (if age <60) 3

Step 2: Add long-acting dihydropyridine CCB 1

Step 3: Increase to full doses 1

Step 4: Add thiazide or thiazide-like diuretic 1

Step 5: Add spironolactone (or if contraindicated: amiloride, doxazosin, eplerenone, clonidine, or β-blocker) 1

Black Patients Without Compelling Indications

Step 1: Low-dose ARB + dihydropyridine CCB OR dihydropyridine CCB + thiazide/thiazide-like diuretic 1

Step 2: Increase to full doses 1

Step 3: Add diuretic or ACE inhibitor/ARB (whichever not yet used) 1

Step 4: Add spironolactone (or alternatives as above) 1

Compelling Indications (Comorbidity-Specific)

Diabetes Mellitus

  • First-line: ACE inhibitor or ARB 3, 4, 3
  • Alternative (if no albuminuria): Thiazide or dihydropyridine CCB 3
  • Target: <130/80 mmHg 4

Chronic Kidney Disease (Proteinuric)

  • First-line: ACE inhibitor or ARB 3
  • Target: <130/80 mmHg 3

Coronary Artery Disease

  • First-line: ACE inhibitor, ARB, or β-blocker 3

Cerebrovascular Disease/Stroke

  • First-line: ACE inhibitor + diuretic combination 3

Isolated Systolic Hypertension

  • First-line: Thiazide diuretic, long-acting dihydropyridine CCB, or ARB 3

Combination Therapy Considerations

Start with 2 drugs if:

  • SBP ≥20 mmHg above target OR DBP ≥10 mmHg above target 3

Preferred combinations:

  • ACE inhibitor + long-acting dihydropyridine CCB (preferred over ACE inhibitor + thiazide in high-risk patients) 3

Avoid:

  • ACE inhibitor + ARB combination (unless compelling indication) 3

6. Follow-Up & Monitoring

Frequency

  • Monthly or every 2 months until BP controlled on 2 consecutive visits 3
  • Achieve target within 3 months 1
  • Once controlled: every 3-6 months 3

At Each Visit

  • Measure BP using standardized technique 2
  • Assess medication adherence (objective methods preferred) 5
  • Monitor for adverse effects 4
  • Review home BP readings (if using home monitoring) 2, 6

Laboratory Monitoring

  • If on ACE inhibitor/ARB: Monitor renal function and potassium 4
  • Periodic reassessment of cardiovascular risk factors 3

7. Team-Based Care & Patient Engagement

Implement team-based care approach involving pharmacists, nurses, patient navigators, and dietitians to improve BP control 2, 7

Key components:

  • Home BP monitoring with clinical support 2, 6
  • Standardized treatment protocols 2, 7
  • Patient education on hypertension consequences, medication necessity, and lifestyle modifications 5
  • Address social determinants of health (medication access, structural barriers) 2
  • Telehealth interventions for improved access and adherence 2

8. Adjunctive Therapies

Lipid Management

  • Treat dyslipidemia per lipid guidelines in all hypertensive patients 3
  • Consider statin therapy in high-risk patients even if not meeting traditional lipid thresholds 3

Antiplatelet Therapy

  • Low-dose aspirin once BP is controlled 3

9. Resistant Hypertension

Definition: BP remains ≥140/90 mmHg despite adherence to ≥3 antihypertensive drugs (including a diuretic) at optimal doses 3

Management:

  1. Confirm true resistance: Verify adherence, rule out white-coat effect with ambulatory/home BP monitoring
  2. Screen for secondary causes 3
  3. Optimize diuretic therapy (switch to thiazide-like diuretic if needed)
  4. Add spironolactone as fourth-line agent 1
  5. Refer to hypertension specialist if still uncontrolled 1

Common Pitfalls to Avoid

  • Inaccurate BP measurement: Always use validated devices with proper cuff size 1
  • White-coat hypertension: Confirm diagnosis with home or ambulatory BP monitoring 1
  • Inadequate medication intensification: Most patients require ≥2 drugs; don't delay escalation 3
  • Ignoring lifestyle modifications: These are foundational and should be emphasized at every visit 3
  • Poor adherence assessment: Use objective measures and address barriers systematically 5
  • Frail elderly patients: Exercise caution; individualize targets to avoid harm 3, 1

References

Related Questions

What are the current hypertension management guidelines for a 51-year-old patient with newly diagnosed hypertension?
What are the differences between the older and newer hypertension treatment guidelines for adults?
How does eating a grilled burger affect blood pressure in healthy adults and hypertensive patients, and what dietary recommendations should be followed?
What are the current primary care guidelines for hypertension management?
What should I know about outpatient hypertension management?
What are the causes of secondary membranous nephropathy in adults?
Can clonidine 0.1 mg be given to a patient with a blood pressure of 170/90 mmHg?
In what circumstances should problematic excipients such as gluten, lactose, glucose, and alcohol be removed from medications?
What is the appropriate dosing and monitoring strategy for methimazole in adults with hyperthyroidism?
What is the recommended dosing schedule for disulfiram (Antabuse)?
What are the indications, dosing schedule, contraindications, and monitoring for intra‑articular hyaluronic acid injection in knee osteoarthritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.